InsidersTradesSigma
Follow the Profusa, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 2 February 2026 (J). Among the most active insiders: Knechtel Fred S.. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Profusa, Inc. is a company focused on developing health monitoring devices based on biosensor technologies. It aims to enhance healthcare through innovative solutions.